JP2004527573A5 - - Google Patents

Download PDF

Info

Publication number
JP2004527573A5
JP2004527573A5 JP2002589024A JP2002589024A JP2004527573A5 JP 2004527573 A5 JP2004527573 A5 JP 2004527573A5 JP 2002589024 A JP2002589024 A JP 2002589024A JP 2002589024 A JP2002589024 A JP 2002589024A JP 2004527573 A5 JP2004527573 A5 JP 2004527573A5
Authority
JP
Japan
Prior art keywords
glycol
composition
composition according
block copolymer
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002589024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004527573A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/013375 external-priority patent/WO2002092107A1/en
Publication of JP2004527573A publication Critical patent/JP2004527573A/ja
Publication of JP2004527573A5 publication Critical patent/JP2004527573A5/ja
Pending legal-status Critical Current

Links

JP2002589024A 2001-04-24 2002-04-24 哺乳類の神経組織損傷の治療のための方法及び組成物 Pending JP2004527573A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28620001P 2001-04-24 2001-04-24
PCT/US2002/013375 WO2002092107A1 (en) 2001-04-24 2002-04-24 Method and compositions for treating mammalian nerve tissue injuries

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009039488A Division JP2009112835A (ja) 2001-04-24 2009-02-23 哺乳類の神経組織損傷の治療のための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2004527573A JP2004527573A (ja) 2004-09-09
JP2004527573A5 true JP2004527573A5 (enExample) 2005-12-22

Family

ID=23097525

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002589024A Pending JP2004527573A (ja) 2001-04-24 2002-04-24 哺乳類の神経組織損傷の治療のための方法及び組成物
JP2009039488A Pending JP2009112835A (ja) 2001-04-24 2009-02-23 哺乳類の神経組織損傷の治療のための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009039488A Pending JP2009112835A (ja) 2001-04-24 2009-02-23 哺乳類の神経組織損傷の治療のための方法及び組成物

Country Status (9)

Country Link
US (4) US7837987B2 (enExample)
EP (1) EP1389121B1 (enExample)
JP (2) JP2004527573A (enExample)
AT (1) ATE546146T1 (enExample)
AU (2) AU2002314758B2 (enExample)
CA (2) CA2445612C (enExample)
ES (1) ES2382899T3 (enExample)
NZ (2) NZ529526A (enExample)
WO (1) WO2002092107A1 (enExample)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582680B1 (en) 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
EP1389121B1 (en) 2001-04-24 2012-02-22 Purdue Research Foundation Method and compositions for treating mammalian nerve tissue injuries
US7147647B2 (en) 2002-04-26 2006-12-12 Medtronic, Inc. Sintered titanium tube for the management of spinal cord injury
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
ATE433759T1 (de) 2003-04-18 2009-07-15 Biogen Idec Inc Polymerkonjugiertes glycosiliertes neublastin
EP2335713A3 (en) * 2004-08-19 2011-11-02 Biogen Idec MA Inc. Neublastin variants
JP4959566B2 (ja) * 2004-08-19 2012-06-27 バイオジェン・アイデック・エムエイ・インコーポレイテッド トランスホーミング増殖因子βファミリータンパク質の折りたたみ
US20060121016A1 (en) * 2004-10-18 2006-06-08 Lee Raphael C Methods and compositions for treatment of free radical injury
ATE432322T1 (de) * 2004-12-21 2009-06-15 Lubrizol Ltd Zusammensetzungen
US20070048731A1 (en) * 2005-05-20 2007-03-01 Neurosilicon High throughput use-dependent assay based on stimulation of cells on a silicon surface
WO2006130599A2 (en) * 2005-05-31 2006-12-07 Warsaw Orthopedic, Inc. Compositions and methods for treating a damaged cardiovascular element
US20070017530A1 (en) * 2005-06-10 2007-01-25 Syed Naweed I Detecting electrical activity and assessing agents for the ability to influence electrical activity
WO2006133555A1 (en) * 2005-06-15 2006-12-21 Neurosilicon (1145990 Alberta Ltd.) Psychotropic drug screening device based on long-term photoconductive stimulation of neurons
WO2006133554A1 (en) * 2005-06-15 2006-12-21 Neurosilicon (1145990 Alberta Ltd.) Electrically stimulating nerve regeneration
JP4907908B2 (ja) * 2005-06-29 2012-04-04 ルネサスエレクトロニクス株式会社 駆動回路及び表示装置
WO2007009235A1 (en) * 2005-07-15 2007-01-25 Neurosilicon (1145990 Alberta Ltd.) Method and apparatus for guiding growth of neurons
US20070213717A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Biological fusion in the vertebral column
US20070227547A1 (en) * 2006-02-14 2007-10-04 Sdgi Holdings, Inc. Treatment of the vertebral column
US20070213822A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Treatment of the vertebral column
US20070213718A1 (en) * 2006-02-14 2007-09-13 Sdgi Holdings, Inc. Treatment of the vertebral column
TWI501774B (zh) * 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
WO2007103182A2 (en) * 2006-03-01 2007-09-13 Biogen Idec Ma Inc. Compostions and methods for administering gdnf ligand family proteins
US8945623B2 (en) 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8840933B2 (en) * 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
JP5583005B2 (ja) * 2007-05-01 2014-09-03 バイオジェン・アイデック・エムエイ・インコーポレイテッド 血管新生を増大させるための組成物および方法
WO2009020964A2 (en) * 2007-08-08 2009-02-12 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof
US20090263507A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
CN102245765B (zh) * 2008-10-21 2015-01-07 通用医院公司 细胞移植
US9244060B2 (en) * 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
EP2411056A1 (en) * 2009-03-26 2012-02-01 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
CA2758118C (en) 2009-04-07 2019-05-21 Catholic Healthcare West Uterine electrical stimulation system and method
US20110230785A1 (en) * 2010-03-16 2011-09-22 ProNerve, LLC Somatosensory Evoked Potential (SSEP) Automated Alert System
CN103153376B (zh) 2010-08-06 2018-04-20 通用医院公司以麻省总医院名义经营 用于细胞处理相关应用的系统和设备
US9872983B2 (en) 2010-10-27 2018-01-23 Dignity Health Uterine electrical stimulation system and method
CA3063888C (en) 2010-10-27 2020-12-22 Dignity Health Uterine electrical stimulation system and method
WO2012161823A1 (en) * 2011-02-25 2012-11-29 The General Hospital Corporation D/B/A Massachusetts General Hospital Nerve coaptation apparatus
US20150127017A1 (en) * 2012-05-18 2015-05-07 Robert E. Garfield Electrical stimulation of the cervix
US11439690B2 (en) * 2013-02-07 2022-09-13 The Cleveland Clinic Foundation Methods of treating spinal cord injury
PL3138031T3 (pl) 2014-04-28 2023-04-11 Yeda Research And Development Co., Ltd. Sposób i urządzenie do przewidywania odpowiedzi na pokarm
GB2536650A (en) 2015-03-24 2016-09-28 Augmedics Ltd Method and system for combining video-based and optic-based augmented reality in a near eye display
MX2020000898A (es) 2017-07-26 2020-10-14 Neuraptive Therapeutics Inc Dispositivo y metodo para crear un campo de contencion de fluido aislado para la administracion de agentes terapeuticos a un nervio.
US12458411B2 (en) 2017-12-07 2025-11-04 Augmedics Ltd. Spinous process clamp
WO2019211741A1 (en) 2018-05-02 2019-11-07 Augmedics Ltd. Registration of a fiducial marker for an augmented reality system
US11766296B2 (en) 2018-11-26 2023-09-26 Augmedics Ltd. Tracking system for image-guided surgery
US12178666B2 (en) 2019-07-29 2024-12-31 Augmedics Ltd. Fiducial marker
US11980506B2 (en) 2019-07-29 2024-05-14 Augmedics Ltd. Fiducial marker
US12337012B2 (en) 2019-09-27 2025-06-24 Virginia Commonwealth University Compositions and methods for restoring or increasing tissue perfusion
US11382712B2 (en) 2019-12-22 2022-07-12 Augmedics Ltd. Mirroring in image guided surgery
EP4093484A4 (en) * 2020-01-21 2023-11-01 The Penn State Research Foundation METHODS AND MATERIALS FOR TREATING NERVE INJURY AND/OR PROMOTING WOUND HEALING
US11389252B2 (en) 2020-06-15 2022-07-19 Augmedics Ltd. Rotating marker for image guided surgery
US20230190676A1 (en) * 2020-07-09 2023-06-22 Musc Foundation For Research Development Methods of protecting cells from insults
US12239385B2 (en) 2020-09-09 2025-03-04 Augmedics Ltd. Universal tool adapter
US11896445B2 (en) 2021-07-07 2024-02-13 Augmedics Ltd. Iliac pin and adapter
US12150821B2 (en) 2021-07-29 2024-11-26 Augmedics Ltd. Rotating marker and adapter for image-guided surgery
US12475662B2 (en) 2021-08-18 2025-11-18 Augmedics Ltd. Stereoscopic display and digital loupe for augmented-reality near-eye display
EP4511809A1 (en) 2022-04-21 2025-02-26 Augmedics Ltd. Systems and methods for medical image visualization
US12268677B2 (en) 2022-04-27 2025-04-08 The Penn State Research Foundation 4-aminopyridine (4-AP) and bone morphogenetic protein 2 (BMP-2)
IL319523A (en) 2022-09-13 2025-05-01 Augmedics Ltd Augmented reality glasses for image-guided medical intervention

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369769A (en) 1980-06-13 1983-01-25 Edwards Charles C Spinal fixation device and method
US4599354A (en) 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief
US6858409B1 (en) * 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US4919140A (en) 1988-10-14 1990-04-24 Purdue Research Foundation Method and apparatus for regenerating nerves
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
NL9000634A (nl) * 1990-03-20 1991-10-16 Catharina Ziekenhuis Stichting Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
CA2075928A1 (en) * 1991-01-11 1992-07-12 Roger W. Hackett Method of detecting circulating antibody types using dried or lyophilized cells or cell-like material
CA2106474C (en) 1991-03-19 2004-02-10 R. Martin Emanuele Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US5470568A (en) 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
US5324322A (en) * 1992-04-20 1994-06-28 Case Western Reserve University Thin film implantable electrode and method of manufacture
US5605687A (en) * 1992-05-15 1997-02-25 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for repair of electrical injury
ES2125285T3 (es) 1992-07-31 1999-03-01 Bristol Myers Squibb Co Derivados inhibidores de la reabsorcion de adenosina de difenil-oxazoles, tiazoles e imidazoles.
CA2085785C (en) 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition
KR970702158A (ko) * 1994-03-28 1997-05-13 하시모토 신이치 평판인쇄판(lithographic form plate)
JPH09315972A (ja) 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
AU751876B2 (en) 1997-03-19 2002-08-29 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6440455B1 (en) 1997-09-02 2002-08-27 Children's Medical Center Corporation Methods for modulating the axonal outgrowth of central nervous system neurons
US7582680B1 (en) * 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
AU4363600A (en) * 1999-04-22 2000-11-10 Department Of The Army, U.S. Government Treatment of and/or prophylaxis against brain and spinal cord injury
EP1389121B1 (en) 2001-04-24 2012-02-22 Purdue Research Foundation Method and compositions for treating mammalian nerve tissue injuries
JP2006517807A (ja) 2002-12-30 2006-08-03 パーデュー・リサーチ・ファウンデーション 中枢神経系の損傷の治療方法

Similar Documents

Publication Publication Date Title
JP2004527573A5 (enExample)
CA2445612A1 (en) Methods and compositions for treating mammalian nerve tissue injuries
ES2209212T3 (es) Bandas no tejidas de filamento continuo auto-coherentes.
CN113332422B (zh) 肽缀合颗粒
Behravesh et al. Synthetic biodegradable polymers for orthopaedic applications.
JP6084770B2 (ja) 制御された薬剤放出速度を有するプロドラッグ及び薬剤−高分子のコンジュゲート
JP2006519238A5 (enExample)
JP2025120178A (ja) バイオポリマー組成物、足場及びデバイス
EP2790667B1 (en) Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent
EP1974726A3 (en) Matrix compositions for controlled delivery of drug substances
RU2003134632A (ru) Двухфазные биоадгезионные композиции, абсорбирующие воду
FI3173073T3 (fi) Liposomeja lääkkeen antamiseen
PE47595A1 (es) Materiales absorbentes que tienen caracteristicas modificadas de la superficie y metodos para fabricar los mismos
WO2004050705A3 (en) Complexes of receptors
CN111770699A (zh) 包括聚烯烃板的鞋底结构和由其形成的鞋类物品
JP2005510521A5 (enExample)
US8263105B2 (en) Biomaterial drug delivery and surface modification compositions
JP2008272467A (ja) コーティングされたフィラメント
Soni et al. Biodegradable block copolymers and their applications for drug delivery
CN1122583A (zh) 将轻质嵌段聚醚酰胺再注塑到热塑性弹性体上
CA2881729A1 (en) Drug delivery composition comprising proteins and biodegradable polyesteramides
WO2004076474A3 (en) Polyethylene glycol modified interferon compositions and methods of use thereof
US20060235084A1 (en) PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions
CA2606396A1 (en) Hydrophilic/hydrophobic polymer networks based on poly(caprolactone fumarate), poly(ethylene glycol fumarate), and copolymers thereof
Mansuri et al. Polymer and Plastic Fundamentals and Its Connecting with Current Environmental, Biomedical, and Pharmaceutical Engineering